{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T15:07:38Z","timestamp":1778684858167,"version":"3.51.4"},"reference-count":92,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T00:00:00Z","timestamp":1772150400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T00:00:00Z","timestamp":1772150400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurol Ther"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1007\/s40120-026-00902-6","type":"journal-article","created":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T12:33:42Z","timestamp":1772195622000},"page":"843-861","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["The Use of Patient-Reported Outcome Measures in Developmental Age: A Complementary Tool for Pediatric Multiple Sclerosis Prognosis"],"prefix":"10.1007","volume":"15","author":[{"given":"Paola","family":"Zaratin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Pia","family":"Amato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giampaolo","family":"Brichetto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anne","family":"Helme","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brenda","family":"Banwell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angelo","family":"Ghezzi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,2,27]]},"reference":[{"issue":"24","key":"902_CR1","doi-asserted-by":"publisher","first-page":"e2764","DOI":"10.1212\/WNL.0000000000007647","volume":"92","author":"KA McKay","year":"2019","unstructured":"McKay KA, Hillert J, Manouchehrinia A. Long-term disability progression of pediatric-onset multiple sclerosis. Neurology. 2019;92(24):e2764\u201373. https:\/\/doi.org\/10.1212\/WNL.0000000000007647.","journal-title":"Neurology"},{"issue":"6","key":"902_CR2","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1001\/jamaneurol.2021.1008","volume":"78","author":"D Baroncini","year":"2021","unstructured":"Baroncini D, Simone M, Iaffaldano P, et al. Risk of persistent disability in patients with pediatric-onset multiple sclerosis. JAMA Neurol. 2021;78(6):726\u201335. https:\/\/doi.org\/10.1001\/jamaneurol.2021.1008.","journal-title":"JAMA Neurol"},{"issue":"8","key":"902_CR3","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1136\/jnnp-2024-335175","volume":"96","author":"G Gombolay","year":"2025","unstructured":"Gombolay G, Johnson L, King R, et al. Worldwide epidemiology of paediatric multiple sclerosis: data from the Multiple Sclerosis International Federation Atlas of MS, third edition. J Neurol Neurosurg Psychiatry. 2025;96(8):814\u201320. https:\/\/doi.org\/10.1136\/jnnp-2024-335175.","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"10","key":"902_CR4","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1016\/S1474-4422(07)70242-9","volume":"6","author":"B Banwell","year":"2007","unstructured":"Banwell B, Ghezzi A, Bar-Or A, Mikaeloff Y, Tardieu M. Multiple sclerosis in children: clinical diagnosis, therapeutic strategies, and future directions. Lancet Neurol. 2007;6(10):887\u2013902. https:\/\/doi.org\/10.1016\/S1474-4422(07)70242-9.","journal-title":"Lancet Neurol"},{"issue":"2","key":"902_CR5","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1177\/1352458520910361","volume":"27","author":"O Abdel-Mannan","year":"2021","unstructured":"Abdel-Mannan O, Cortese R, Wassmer E, et al. Primary progressive multiple sclerosis presenting under the age of 18\u00a0years: fact or fiction? Mult Scler. 2021;27(2):309\u201314. https:\/\/doi.org\/10.1177\/1352458520910361.","journal-title":"Mult Scler"},{"issue":"1","key":"902_CR6","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1001\/archneurol.2008.505","volume":"66","author":"MP Gorman","year":"2009","unstructured":"Gorman MP, Healy BC, Polgar-Turcsanyi M, Chitnis T. Increased relapse rate in pediatric-onset compared with adult-onset multiple sclerosis. Arch Neurol. 2009;66(1):54\u20139. https:\/\/doi.org\/10.1001\/archneurol.2008.505.","journal-title":"Arch Neurol"},{"key":"902_CR7","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1016\/j.msard.2013.06.004","volume":"3","author":"LA Benson","year":"2014","unstructured":"Benson LA, Healy BC, Gorman MP, et al. Elevated relapse rates in pediatric compared to adult MS persist for at least 6\u00a0years. Mult Scler Relat Disord. 2014;3:186\u201393.","journal-title":"Mult Scler Relat Disord"},{"issue":"9","key":"902_CR8","doi-asserted-by":"publisher","first-page":"2733","DOI":"10.1093\/brain\/awaa199","volume":"143","author":"T Chitnis","year":"2020","unstructured":"Chitnis T, Aaen G, Belman A, et al. Improved relapse recovery in paediatric compared to adult multiple sclerosis. Brain. 2020;143(9):2733\u201341. https:\/\/doi.org\/10.1093\/brain\/awaa199.","journal-title":"Brain"},{"issue":"9","key":"902_CR9","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1016\/j.clineuro.2008.04.009","volume":"110","author":"C Renoux","year":"2008","unstructured":"Renoux C, Vukusic S, Confavreux C. The natural history of multiple sclerosis with childhood onset. Clin Neurol Neurosurg. 2008;110(9):897\u2013904. https:\/\/doi.org\/10.1016\/j.clineuro.2008.04.009.","journal-title":"Clin Neurol Neurosurg"},{"key":"902_CR10","doi-asserted-by":"publisher","unstructured":"Harding KE, Liang K, Cossburn MD, et al. Long-term outcome of paediatric-onset multiple sclerosis: a population-based study. J Neurol Neurosurg Psychiatry. 2013;84(2):141\u20137. https:\/\/doi.org\/10.1136\/jnnp-2012-303996.","DOI":"10.1136\/jnnp-2012-303996"},{"issue":"4","key":"902_CR11","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1002\/ana.26322","volume":"91","author":"E De Meo","year":"2022","unstructured":"De Meo E, Filippi M, Trojano M, et al. Comparing natural history of early and late onset pediatric multiple sclerosis. Ann Neurol. 2022;91(4):483\u201395. https:\/\/doi.org\/10.1002\/ana.26322.","journal-title":"Ann Neurol"},{"issue":"4","key":"902_CR12","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1007\/s40120-024-00633-6","volume":"13","author":"A Ghezzi","year":"2024","unstructured":"Ghezzi A. Old and new strategies in the treatment of pediatric multiple sclerosis: a personal view for a new treatment approach. Neurol Ther. 2024;13(4):949\u201363. https:\/\/doi.org\/10.1007\/s40120-024-00633-6.","journal-title":"Neurol Ther"},{"issue":"17","key":"902_CR13","doi-asserted-by":"publisher","DOI":"10.3390\/jcm11175226","volume":"11","author":"L Rosa","year":"2022","unstructured":"Rosa L, Petracca M, Carotenuto A, et al. Quality of life changes in early-onset multiple sclerosis: a 4-year follow-up study. J Clin Med. 2022;11(17):5226. https:\/\/doi.org\/10.3390\/jcm11175226.","journal-title":"J Clin Med"},{"issue":"1","key":"902_CR14","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1007\/s00415-019-09554-z","volume":"267","author":"M Margoni","year":"2020","unstructured":"Margoni M, Rinaldi F, Riccardi A, Franciotta S, Perini P, Gallo P. No evidence of disease activity including cognition (NEDA-3 plus) in na\u00efve pediatric multiple sclerosis patients treated with natalizumab. J Neurol. 2020;267(1):100\u20135. https:\/\/doi.org\/10.1007\/s00415-019-09554-z.","journal-title":"J Neurol"},{"key":"902_CR15","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2025.105921","volume":"120","author":"M Filippi","year":"2025","unstructured":"Filippi M, Margoni M, Banwell B, et al. Smouldering disease in paediatric-onset multiple sclerosis. EBioMedicine. 2025;120:105921. https:\/\/doi.org\/10.1016\/j.ebiom.2025.105921.","journal-title":"EBioMedicine"},{"issue":"1","key":"902_CR16","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1001\/jamaneurol.2023.4455","volume":"81","author":"P Iaffaldano","year":"2024","unstructured":"Iaffaldano P, Portaccio E, Lucisano G, et al. Multiple Sclerosis progression and relapse activity in children. JAMA Neurol. 2024;81(1):50\u20138. https:\/\/doi.org\/10.1001\/jamaneurol.2023.4455.","journal-title":"JAMA Neurol"},{"issue":"13","key":"902_CR17","doi-asserted-by":"publisher","first-page":"e1844","DOI":"10.1212\/WNL.0000000000010414","volume":"95","author":"JD Santoro","year":"2020","unstructured":"Santoro JD, Waltz M, Aaen G, et al. Pediatric Multiple Sclerosis Severity Score in a large US cohort. Neurology. 2020;95(13):e1844\u201353. https:\/\/doi.org\/10.1212\/WNL.0000000000010414.","journal-title":"Neurology"},{"issue":"7","key":"902_CR18","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1111\/dmcn.14889","volume":"63","author":"J Carroll","year":"2021","unstructured":"Carroll J. The International Alliance of Academies of Childhood Disability Knowledge Hub. Dev Med Child Neurol. 2021;63(7):761. https:\/\/doi.org\/10.1111\/dmcn.14889.","journal-title":"Dev Med Child Neurol"},{"issue":"11","key":"902_CR19","doi-asserted-by":"publisher","first-page":"1250","DOI":"10.1111\/dmcn.14629","volume":"62","author":"M Duncan","year":"2020","unstructured":"Duncan M, Carroll S, Cockburn R, et al. Psychosocial impact of paediatric demyelinating disorders: a scoping review. Dev Med Child Neurol. 2020;62(11):1250\u20138. https:\/\/doi.org\/10.1111\/dmcn.14629.","journal-title":"Dev Med Child Neurol"},{"issue":"2","key":"902_CR20","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1007\/s40120-024-00706","volume":"14","author":"P Zaratin","year":"2025","unstructured":"Zaratin P, Soelberg S\u00f8rensen P, Fern\u00e1ndez \u00d3, Comi G. Patient-generated data as indicators of impact of multidisciplinary and multi-stakeholder health care systems, in the age of personalised medicine. Neurol Ther. 2025;14(2):437\u201346. https:\/\/doi.org\/10.1007\/s40120-024-00706.","journal-title":"Neurol Ther"},{"key":"902_CR21","doi-asserted-by":"publisher","first-page":"1867","DOI":"10.1007\/s40120-023-00535-z","volume":"12","author":"A Ghezzi","year":"2023","unstructured":"Ghezzi A, Neuteboom RF. Neurofilament light chain in adult and pediatric multiple sclerosis: a promising biomarker to better characterize disease activity and personalize MS treatment. Neurol Ther. 2023;12:1867\u201381. https:\/\/doi.org\/10.1007\/s40120-023-00535-z.","journal-title":"Neurol Ther"},{"issue":"11","key":"902_CR22","doi-asserted-by":"publisher","first-page":"1444","DOI":"10.1212\/wnl.33.11.1444","volume":"33","author":"JF Kurtzke","year":"1983","unstructured":"Kurtzke JF. Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology. 1983;33(11):1444\u201352. https:\/\/doi.org\/10.1212\/wnl.33.11.1444.","journal-title":"Neurology"},{"issue":"12","key":"902_CR23","doi-asserted-by":"publisher","first-page":"1627","DOI":"10.1177\/1352458517729465","volume":"23","author":"D Ontaneda","year":"2017","unstructured":"Ontaneda D, Cohen JA, Amato MP. Clinical outcome measures for progressive MS trials. Mult Scler. 2017;23(12):1627\u201335. https:\/\/doi.org\/10.1177\/1352458517729465.","journal-title":"Mult Scler"},{"issue":"12","key":"902_CR24","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.1212\/WNL.0b013e318288694e","volume":"80","author":"T Chitnis","year":"2013","unstructured":"Chitnis T, Tardieu M, Amato MP, et al. International Pediatric MS Study Group Clinical Trials Summit: meeting report. Neurology. 2013;80(12):1161\u20138. https:\/\/doi.org\/10.1212\/WNL.0b013e318288694e.","journal-title":"Neurology"},{"issue":"3_suppl","key":"902_CR25","doi-asserted-by":"publisher","first-page":"1148","DOI":"10.1177\/13524585241269220","volume":"30","author":"G Brichetto","year":"2024","unstructured":"Brichetto G, Helme A, Ghirotto L, et al. ECTRIMS 2024 Late Breaking Poster. Multiple Scler J. 2024;30(3_suppl):1148\u2013211. https:\/\/doi.org\/10.1177\/13524585241269220.","journal-title":"Multiple Scler J"},{"issue":"4","key":"902_CR26","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1177\/13524585990050040","volume":"5","author":"JS Fischer","year":"1999","unstructured":"Fischer JS, Rudick RA, Cutter GR, Reingold SC, National MS Society Clinical Outcomes Assessment Task Force. The Multiple Sclerosis Functional Composite Measure (MSFC): an integrated approach to MS clinical outcome assessment. Mult Scler. 1999;5(4):244\u201350. https:\/\/doi.org\/10.1177\/13524585990050040.","journal-title":"Mult Scler"},{"issue":"2","key":"902_CR27","doi-asserted-by":"publisher","DOI":"10.1177\/2055217319846141","volume":"5","author":"JN Brenton","year":"2019","unstructured":"Brenton JN, Koshiya H, Woolbright E, Goldman MD. The multiple sclerosis functional composite and symbol digit modalities test as outcome measures in pediatric multiple sclerosis. Multiple Scler J Exp Transl Clin. 2019;5(2):2055217319846141. https:\/\/doi.org\/10.1177\/2055217319846141.","journal-title":"Multiple Scler J Exp Transl Clin"},{"issue":"9","key":"902_CR28","doi-asserted-by":"publisher","first-page":"1482","DOI":"10.1111\/ene.13102","volume":"23","author":"B Nourbakhsh","year":"2016","unstructured":"Nourbakhsh B, Julian L, Waubant E. Fatigue and depression predict quality of life in patients with early multiple sclerosis: a longitudinal study. Eur J Neurol. 2016;23(9):1482\u20136. https:\/\/doi.org\/10.1111\/ene.13102.","journal-title":"Eur J Neurol"},{"key":"902_CR29","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.msard.2016.08.012","volume":"10","author":"AT Waldman","year":"2016","unstructured":"Waldman AT, Chahin S, Lavery AM, et al. Binocular low-contrast letter acuity and the symbol digit modalities test improve the ability of the Multiple Sclerosis Functional Composite to predict disease in pediatric multiple sclerosis. Mult Scler Relat Disord. 2016;10:73\u20138. https:\/\/doi.org\/10.1016\/j.msard.2016.08.012.","journal-title":"Mult Scler Relat Disord"},{"key":"902_CR30","doi-asserted-by":"publisher","DOI":"10.1016\/j.msard.2019.08.010","volume":"36","author":"K Storm Van's Gravesande","year":"2019","unstructured":"Storm Van\u2019s Gravesande K, Blaschek A, Calabrese P, et al. Fatigue and depression predict health-related quality of life in patients with pediatric-onset multiple sclerosis. Mult Scler Relat Disord. 2019;36:101368. https:\/\/doi.org\/10.1016\/j.msard.2019.08.010.","journal-title":"Mult Scler Relat Disord"},{"issue":"11","key":"902_CR31","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1016\/S1474-4422(19)30357-6","volume":"18","author":"The Lancet Neurology","year":"2019","unstructured":"The Lancet Neurology. Patient-reported outcomes in the spotlight. Lancet Neurol. 2019;18(11):981. https:\/\/doi.org\/10.1016\/S1474-4422(19)30357-6.","journal-title":"Lancet Neurol"},{"key":"902_CR32","doi-asserted-by":"publisher","DOI":"10.1016\/j.msard.2022.103757","volume":"61","author":"P Zaratin","year":"2022","unstructured":"Zaratin P, Vermersch P, Amato MP, et al. The agenda of the global patient reported outcomes for multiple sclerosis (PROMS) initiative: progresses and open questions. Mult Scler Relat Disord. 2022;61:103757. https:\/\/doi.org\/10.1016\/j.msard.2022.103757.","journal-title":"Mult Scler Relat Disord"},{"key":"902_CR33","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2024.1407257","volume":"15","author":"P Zaratin","year":"2024","unstructured":"Zaratin P, Samadzadeh S, Sefero\u011flu M, et al. The Global Patient-Reported Outcomes for Multiple Sclerosis Initiative: bridging the gap between clinical research and care - updates at the 2023 plenary event. Front Neurol. 2024;15:1407257. https:\/\/doi.org\/10.3389\/fneur.2024.1407257.","journal-title":"Front Neurol"},{"key":"902_CR34","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2024.1408636","volume":"11","author":"D Almeida","year":"2024","unstructured":"Almeida D, Umuhire D, Gonzalez-Quevedo R, et al. Leveraging patient experience data to guide medicines development, regulation, access decisions and clinical care in the EU. Front Med. 2024;11:1408636. https:\/\/doi.org\/10.3389\/fmed.2024.1408636.","journal-title":"Front Med"},{"key":"902_CR35","doi-asserted-by":"publisher","DOI":"10.1186\/s40900-023-00503-9","volume":"9","author":"T Willgoss","year":"2023","unstructured":"Willgoss T, Escontrias OA, Scrafton C, et al. Co-creation of the global patient experience data navigator: a multi-stakeholder initiative to ensure the patient voice is represented in health decision-making. Res Involv Engag. 2023;9:92. https:\/\/doi.org\/10.1186\/s40900-023-00503-9.","journal-title":"Res Involv Engag"},{"key":"902_CR36","unstructured":"Focus Area: Patient-Reported Outcomes and other Clinical Outcome Assessments, FDA 01\/30\/2025, https:\/\/www.fda.gov\/science-research\/focus-areas-regulatory-science-report\/focus-area-patient-reported-outcomes-and-other-clinical-outcome-assessments."},{"key":"902_CR37","unstructured":"Clinical Outcome Assessment (COA): Frequently Asked Questions, FDA 12\/02\/2020 https:\/\/www.fda.gov\/about-fda\/clinical-outcome-assessment-coa-frequently-asked-questions."},{"issue":"10","key":"902_CR38","doi-asserted-by":"publisher","first-page":"1402","DOI":"10.1177\/1352458519857075","volume":"25","author":"G Brichetto","year":"2019","unstructured":"Brichetto G, Pedull\u00e0 L, Podda J, Tacchino A. Beyond center-based testing: understanding and improving functioning with wearable technology in MS. Mult Scler. 2019;25(10):1402\u201311. https:\/\/doi.org\/10.1177\/1352458519857075.","journal-title":"Mult Scler"},{"issue":"4","key":"902_CR39","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1016\/j.jval.2013.04.004","volume":"16","author":"LS Matza","year":"2013","unstructured":"Matza LS, Patrick D, Riley AW, et al. Pediatric patient-reported outcome instruments for research to support medical product labeling: report of the ISPOR PRO Good Research Practices for the Assessment of Children and Adolescents Task Force. Value Health. 2013;16(4):461\u201379.","journal-title":"Value Health"},{"key":"902_CR40","unstructured":"Kusanto B, Byrom B, Busner J PROs and ObsROs in Pediatric Clinical Trials: Measure Selection and Implementation DIA Global Forum, 17\/10\/2024. https:\/\/globalforum.diaglobal.org\/issue\/october-2024\/pros-and-obsros-in-pediatric-clinical-trials-measure-selection-and-implementation\/."},{"issue":"1","key":"902_CR41","doi-asserted-by":"publisher","DOI":"10.1002\/dad2.12217","volume":"13","author":"F \u00d6hman","year":"2021","unstructured":"\u00d6hman F, Hassenstab J, Berron D, Sch\u00f6ll M, Papp KV. Current advances in digital cognitive assessment for preclinical Alzheimer\u2019s disease. Alzheimers Dement (Amst). 2021;13(1):e12217. https:\/\/doi.org\/10.1002\/dad2.12217.","journal-title":"Alzheimers Dement (Amst)"},{"issue":"10","key":"902_CR42","doi-asserted-by":"publisher","first-page":"6881","DOI":"10.1002\/alz.14154","volume":"20","author":"CR Vanderlip","year":"2024","unstructured":"Vanderlip CR, Stark CEL, Alzheimer\u2019s Disease Neuroimaging Initiative. Digital cognitive assessments as low-burden markers for predicting future cognitive decline and tau accumulation across the Alzheimer\u2019s spectrum. Alzheimers Dement. 2024;20(10):6881\u201395. https:\/\/doi.org\/10.1002\/alz.14154.","journal-title":"Alzheimers Dement"},{"key":"902_CR43","doi-asserted-by":"publisher","DOI":"10.1002\/trc2.12069","volume":"6","author":"E McDade","year":"2020","unstructured":"McDade E, Bednar MM, Brashear HR, et al. The pathway to secondary prevention of Alzheimer\u2019s disease. Alzheimers Dement (N Y). 2020;6:12069. https:\/\/doi.org\/10.1002\/trc2.12069.","journal-title":"Alzheimers Dement (N Y)"},{"issue":"9","key":"902_CR44","doi-asserted-by":"publisher","first-page":"1234","DOI":"10.1177\/1352458517717341","volume":"24","author":"L Ruano","year":"2018","unstructured":"Ruano L, Branco M, Portaccio E, et al. Patients with pediatriconset multiple sclerosis are at higher risk of cognitive impairment in adulthood: an Italian collaborative study. Mult Scler. 2018;24(9):1234\u201342. https:\/\/doi.org\/10.1177\/1352458517717341.","journal-title":"Mult Scler"},{"issue":"9","key":"902_CR45","doi-asserted-by":"publisher","first-page":"1028","DOI":"10.1001\/jamaneurol.2019.1546","volume":"76","author":"KA McKay","year":"2019","unstructured":"McKay KA, Manouchehrinia A, Berrigan L, Fisk JD, Olsson T, Hillert J. Long-term cognitive outcomes in patients with pediatric-onset vs adult-onset multiple sclerosis. JAMA Neurol. 2019;76(9):1028\u201334. https:\/\/doi.org\/10.1001\/jamaneurol.2019.1546.","journal-title":"JAMA Neurol"},{"issue":"16","key":"902_CR46","doi-asserted-by":"publisher","first-page":"e1626","DOI":"10.1212\/WNL.0000000000200115","volume":"98","author":"E Portaccio","year":"2022","unstructured":"Portaccio E, Bellinvia A, Razzolini L, et al. Long-term cognitive outcomes and socioprofessional attainment in people with multiple sclerosis with childhood onset. Neurology. 2022;98(16):e1626\u201336. https:\/\/doi.org\/10.1212\/WNL.0000000000200115.","journal-title":"Neurology"},{"issue":"4","key":"902_CR47","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1001\/jamaneurol.2020.5520","volume":"78","author":"KA McKay","year":"2021","unstructured":"McKay KA, Friberg E, Razaz N, Alexanderson K, Hillert J. Long-term socioeconomic outcomes associated with pediatric-onset multiple sclerosis. JAMA Neurol. 2021;78(4):478\u201382. https:\/\/doi.org\/10.1001\/jamaneurol.2020.5520.","journal-title":"JAMA Neurol"},{"issue":"2","key":"902_CR48","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1177\/1352458520959673","volume":"27","author":"MS Boesen","year":"2021","unstructured":"Boesen MS, Blinkenberg M, Thygesen LC, Eriksson F, Magyari M. School performance, psychiatric comorbidity, and healthcare utilization in pediatric multiple sclerosis: a nationwide population-based observational study. Mult Scler. 2021;27(2):259\u201367. https:\/\/doi.org\/10.1177\/1352458520959673.","journal-title":"Mult Scler"},{"issue":"4","key":"902_CR49","doi-asserted-by":"publisher","DOI":"10.3390\/brainsci11040442","volume":"11","author":"E Portaccio","year":"2021","unstructured":"Portaccio E, De Meo E, Bellinvia A, Amato MP. Cognitive issues in pediatric multiple sclerosis. Brain Sci. 2021;11(4):442. https:\/\/doi.org\/10.3390\/brainsci11040442.","journal-title":"Brain Sci"},{"issue":"18","key":"902_CR50","doi-asserted-by":"publisher","first-page":"1744","DOI":"10.1212\/WNL.0000000000003884","volume":"88","author":"B Aubert-Broche","year":"2017","unstructured":"Aubert-Broche B, Weier K, Longoni G, et al. Monophasic demyelination reduces brain growth in children. Neurology. 2017;88(18):1744\u201350. https:\/\/doi.org\/10.1212\/WNL.0000000000003884.","journal-title":"Neurology"},{"issue":"15","key":"902_CR51","doi-asserted-by":"publisher","first-page":"e1709","DOI":"10.1212\/WNL.0000000000007267","volume":"92","author":"E De Meo","year":"2019","unstructured":"De Meo E, Meani A, Moiola L, et al. Dynamic gray matter volume changes in pediatric multiple sclerosis: a 3.5\u00a0year MRI study. Neurology. 2019;92(15):e1709\u201323. https:\/\/doi.org\/10.1212\/WNL.0000000000007267.","journal-title":"Neurology"},{"issue":"1-2","key":"902_CR52","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.jns.2014.04.006","volume":"341","author":"LE Charvet","year":"2014","unstructured":"Charvet LE, Beekman R, Amadiume N, Belman AL, Krupp LB. The Symbol Digit Modalities Test is an effective cognitive screen in pediatric onset multiple sclerosis (MS). J Neurol Sci. 2014;341(1\u20132):79\u201384. https:\/\/doi.org\/10.1016\/j.jns.2014.04.006.","journal-title":"J Neurol Sci"},{"issue":"6","key":"902_CR53","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1177\/1352458511431076","volume":"18","author":"DW Langdon","year":"2012","unstructured":"Langdon DW, Amato MP, Boringa J, et al. Recommendations for a Brief International Cognitive Assessment for Multiple Sclerosis (BICAMS). Mult Scler. 2012;18(6):891\u20138. https:\/\/doi.org\/10.1177\/1352458511431076.","journal-title":"Mult Scler"},{"issue":"4","key":"902_CR54","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1177\/1352458517701588","volume":"24","author":"LE Charvet","year":"2018","unstructured":"Charvet LE, Shaw M, Frontario A, Langdon D, Krupp LB. Cognitive impairment in pediatric-onset multiple sclerosis is detected by the Brief International Cognitive Assessment for Multiple Sclerosis and computerized cognitive testing. Mult Scler. 2018;24(4):512\u20139. https:\/\/doi.org\/10.1177\/1352458517701588.","journal-title":"Mult Scler"},{"issue":"7","key":"902_CR55","doi-asserted-by":"publisher","first-page":"1042","DOI":"10.1212\/wnl.59.7.1042","volume":"59","author":"D Darby","year":"2002","unstructured":"Darby D, Maruff P, Collie A, McStephen M. Mild cognitive impairment can be detected by multiple assessments in a single day. Neurology. 2002;59(7):1042\u20136. https:\/\/doi.org\/10.1212\/wnl.59.7.1042.","journal-title":"Neurology"},{"issue":"4","key":"902_CR56","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1007\/s10072-017-2813-0","volume":"38","author":"S Bigi","year":"2017","unstructured":"Bigi S, Marrie RA, Till C, et al. The computer-based symbol digit modalities test: establishing age-expected performance in healthy controls and evaluation of pediatric MS patients. Neurol Sci. 2017;38(4):635\u201342. https:\/\/doi.org\/10.1007\/s10072-017-2813-0.","journal-title":"Neurol Sci"},{"issue":"8","key":"902_CR57","doi-asserted-by":"publisher","first-page":"1422","DOI":"10.1212\/01.WNL.0000158474.24191.BC","volume":"64","author":"WS MacAllister","year":"2005","unstructured":"MacAllister WS, Belman AL, Milazzo M, et al. Cognitive functioning in children and adolescents with multiple sclerosis. Neurology. 2005;64(8):1422\u20135. https:\/\/doi.org\/10.1212\/01.WNL.0000158474.24191.BC.","journal-title":"Neurology"},{"issue":"20","key":"902_CR58","doi-asserted-by":"publisher","first-page":"1891","DOI":"10.1212\/01.wnl.0000312276.23177.fa","volume":"70","author":"MP Amato","year":"2008","unstructured":"Amato MP, Goretti B, Ghezzi A, et al. Cognitive and psychosocial features of childhood and juvenile MS. Neurology. 2008;70(20):1891\u20137. https:\/\/doi.org\/10.1212\/01.wnl.0000312276.23177.fa.","journal-title":"Neurology"},{"issue":"3","key":"902_CR59","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1037\/a0022051","volume":"25","author":"C Till","year":"2011","unstructured":"Till C, Ghassemi R, Aubert-Broche B, et al. MRI correlates of cognitive impairment in childhood-onset multiple sclerosis. Neuropsychology. 2011;25(3):319\u201332. https:\/\/doi.org\/10.1037\/a0022051.","journal-title":"Neuropsychology"},{"issue":"1","key":"902_CR60","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1177\/0883073812464816","volume":"28","author":"L Julian","year":"2013","unstructured":"Julian L, Serafin D, Charvet L, et al. Cognitive impairment occurs in children and adolescents with multiple sclerosis: results from a United States network. J Child Neurol. 2013;28(1):102\u20137. https:\/\/doi.org\/10.1177\/0883073812464816.","journal-title":"J Child Neurol"},{"issue":"14","key":"902_CR61","doi-asserted-by":"publisher","first-page":"1938","DOI":"10.1177\/1352458519891984","volume":"26","author":"AI Wallach","year":"2020","unstructured":"Wallach AI, Waltz M, Casper TC, et al. Cognitive processing speed in pediatric-onset multiple sclerosis: baseline characteristics of impairment and prediction of decline. Mult Scler. 2020;26(14):1938\u201347. https:\/\/doi.org\/10.1177\/1352458519891984.","journal-title":"Mult Scler"},{"issue":"1","key":"902_CR62","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1177\/13524585221123978","volume":"29","author":"LB Krupp","year":"2023","unstructured":"Krupp LB, Waubant E, Waltz M, et al. A new look at cognitive functioning in pediatric MS. Mult Scler. 2023;29(1):140\u20139. https:\/\/doi.org\/10.1177\/13524585221123978.","journal-title":"Mult Scler"},{"issue":"3","key":"902_CR63","doi-asserted-by":"publisher","DOI":"10.2196\/mhealth.4269","volume":"3","author":"A Tacchino","year":"2015","unstructured":"Tacchino A, Pedull\u00e0 L, Bonzano L, et al. A new app for at-home cognitive training: description and pilot testing on patients with multiple sclerosis. JMIR Mhealth Uhealth. 2015;3(3):e85. https:\/\/doi.org\/10.2196\/mhealth.4269.","journal-title":"JMIR Mhealth Uhealth"},{"issue":"2","key":"902_CR64","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1007\/s10072-024-07886-x","volume":"46","author":"C Masciulli","year":"2025","unstructured":"Masciulli C, Portaccio E, Goretti B, et al. Home-based, computer-assisted cognitive rehabilitation for attention in pediatric onset multiple sclerosis: a randomized, multicenter pilot study. Neurol Sci. 2025;46(2):1013\u20137. https:\/\/doi.org\/10.1007\/s10072-024-07886-x.","journal-title":"Neurol Sci"},{"key":"902_CR65","doi-asserted-by":"publisher","DOI":"10.3389\/fnhum.2020.00245","volume":"14","author":"S Cavedoni","year":"2020","unstructured":"Cavedoni S, Chirico A, Pedroli E, Cipresso P, Riva G. Digital biomarkers for the early detection of mild cognitive impairment: artificial intelligence meets virtual reality. Front Hum Neurosci. 2020;14:245. https:\/\/doi.org\/10.3389\/fnhum.2020.00245.","journal-title":"Front Hum Neurosci"},{"key":"902_CR66","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1487709","volume":"16","author":"A Helme","year":"2025","unstructured":"Helme A, Kalra D, Brichetto G, et al. Artificial intelligence and science of patient input: a perspective from people with multiple sclerosis. Front Immunol. 2025;16:1487709. https:\/\/doi.org\/10.3389\/fimmu.2025.1487709.","journal-title":"Front Immunol"},{"key":"902_CR67","doi-asserted-by":"publisher","DOI":"10.1186\/s12961-022-00825-2","volume":"20","author":"P Zaratin","year":"2022","unstructured":"Zaratin P, Bertorello D, Guglielmino R, et al. The MULTI-ACT model: the path forward for participatory and anticipatory governance in health research and care. Health Res Policy Syst. 2022;20:22. https:\/\/doi.org\/10.1186\/s12961-022-00825-2.","journal-title":"Health Res Policy Syst"},{"issue":"1","key":"902_CR68","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1111\/hex.13650","volume":"26","author":"E McCabe","year":"2023","unstructured":"McCabe E, Amarbayan MM, Rabi S, et al. Youth engagement in mental health research: a systematic review. Health Expect. 2023;26(1):30\u201350. https:\/\/doi.org\/10.1111\/hex.13650.","journal-title":"Health Expect"},{"issue":"1","key":"902_CR69","doi-asserted-by":"publisher","DOI":"10.1186\/s40900-023-00534-2","volume":"9","author":"P Zaratin","year":"2023","unstructured":"Zaratin P, Khan U, Graffigna G. Comment on \u201cReflections on patient engagement by patient partners: how it can go wrong.\u201d Res Involv Engagem. 2023;9(1):122. https:\/\/doi.org\/10.1186\/s40900-023-00534-2.","journal-title":"Res Involv Engagem"},{"issue":"6","key":"902_CR70","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1586\/14737167.5.6.705","volume":"5","author":"JW Varni","year":"2005","unstructured":"Varni JW, Burwinkle TM, Seid M. The PedsQL as a pediatric patient-reported outcome: reliability and validity of the PedsQL Measurement Model in 25,000 children. Expert Rev Pharmacoecon Outcomes Res. 2005;5(6):705\u201319. https:\/\/doi.org\/10.1586\/14737167.5.6.705.","journal-title":"Expert Rev Pharmacoecon Outcomes Res"},{"issue":"9","key":"902_CR71","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1111\/dmcn.14870","volume":"63","author":"N Ow","year":"2021","unstructured":"Ow N, Mozafarinia M, Mayo NE. Quality of life measures in pediatric multiple sclerosis: a systematic review and meta-analysis. Dev Med Child Neurol. 2021;63(9):1051\u20138. https:\/\/doi.org\/10.1111\/dmcn.14870.","journal-title":"Dev Med Child Neurol"},{"issue":"16","key":"902_CR72","doi-asserted-by":"publisher","DOI":"10.3390\/ijerph18168645","volume":"18","author":"S Mroskov\u00e1","year":"2021","unstructured":"Mroskov\u00e1 S, Kl\u00edmov\u00e1 E, Majern\u00edkov\u00e1 \u013d, Tk\u00e1\u010dov\u00e1 \u013d. Quality of life of children and adolescents with multiple sclerosis-a literature review of the quantitative evidence. Int J Environ Res Public Health. 2021;18(16):8645. https:\/\/doi.org\/10.3390\/ijerph18168645.","journal-title":"Int J Environ Res Public Health"},{"key":"902_CR73","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.msard.2016.08.013","volume":"10","author":"S Ostojic","year":"2016","unstructured":"Ostojic S, Stevanovic D, Jancic J. Quality of life and its correlates in adolescent multiple sclerosis patients. Mult Scler Relat Disord. 2016;10:57\u201362. https:\/\/doi.org\/10.1016\/j.msard.2016.08.013.","journal-title":"Mult Scler Relat Disord"},{"issue":"4","key":"902_CR74","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1016\/j.ejpn.2009.09.004","volume":"14","author":"IA Ketelslegers","year":"2010","unstructured":"Ketelslegers IA, Catsman-Berrevoets C, Boon M, et al. Fatigue and depression in children with multiple sclerosis and monophasic variants. Eur J Paediatr Neurol. 2010;14(4):320\u20135. https:\/\/doi.org\/10.1016\/j.ejpn.2009.09.004.","journal-title":"Eur J Paediatr Neurol"},{"issue":"2","key":"902_CR75","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1111\/dmcn.14242","volume":"62","author":"A Florea","year":"2020","unstructured":"Florea A, Maurey H, Le Sauter M, et al. Fatigue, depression, and quality of life in children with multiple sclerosis: a comparative study with other demyelinating diseases. Dev Med Child Neurol. 2020;62(2):241\u20134. https:\/\/doi.org\/10.1111\/dmcn.14242.","journal-title":"Dev Med Child Neurol"},{"issue":"7","key":"902_CR76","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1177\/1352458517706038","volume":"24","author":"L Toussaint-Duyster","year":"2018","unstructured":"Toussaint-Duyster L, Wong YYM, Van der Cammen-van Zijp MH, et al. Fatigue and physical functioning in children with multiple sclerosis and acute disseminated encephalomyelitis. Mult Scler. 2018;24(7):982\u201390. https:\/\/doi.org\/10.1177\/1352458517706038.","journal-title":"Mult Scler"},{"issue":"3","key":"902_CR77","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1177\/1352458511420846","volume":"18","author":"B Goretti","year":"2012","unstructured":"Goretti B, Portaccio E, Ghezzi A, et al. Fatigue and its relationships with cognitive functioning and depression in paediatric multiple sclerosis. Mult Scler. 2012;18(3):329\u201334. https:\/\/doi.org\/10.1177\/1352458511420846.","journal-title":"Mult Scler"},{"issue":"1","key":"902_CR78","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/j.ejpn.2015.08.005","volume":"20","author":"R Lanzillo","year":"2016","unstructured":"Lanzillo R, Chiodi A, Carotenuto A, et al. Quality of life and cognitive functions in early onset multiple sclerosis. Eur J Paediatr Neurol. 2016;20(1):158\u201363. https:\/\/doi.org\/10.1016\/j.ejpn.2015.08.005.","journal-title":"Eur J Paediatr Neurol"},{"issue":"2","key":"902_CR79","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.pediatrneurol.2010.03.007","volume":"43","author":"EM Mowry","year":"2010","unstructured":"Mowry EM, Julian LJ, Im-Wang S, et al. Health-related quality of life is reduced in pediatric multiple sclerosis. Pediatr Neurol. 2010;43(2):97\u2013102. https:\/\/doi.org\/10.1016\/j.pediatrneurol.2010.03.007.","journal-title":"Pediatr Neurol"},{"issue":"12","key":"902_CR80","doi-asserted-by":"publisher","first-page":"1661","DOI":"10.1177\/1352458518796676","volume":"25","author":"J O\u2019Mahony","year":"2019","unstructured":"O\u2019Mahony J, Marrie RA, Laporte A, et al. Pediatric-onset multiple sclerosis is associated with reduced parental health-related quality of life and family functioning. Mult Scler. 2019;25(12):1661\u201372. https:\/\/doi.org\/10.1177\/1352458518796676.","journal-title":"Mult Scler"},{"issue":"12","key":"902_CR81","doi-asserted-by":"publisher","first-page":"1502","DOI":"10.1177\/1352458509345902","volume":"15","author":"WS MacAllister","year":"2009","unstructured":"MacAllister WS, Christodoulou C, Troxell R, et al. Fatigue and quality of life in pediatric multiple sclerosis. Mult Scler. 2009;15(12):1502\u20138. https:\/\/doi.org\/10.1177\/1352458509345902.","journal-title":"Mult Scler"},{"issue":"11","key":"902_CR82","doi-asserted-by":"publisher","first-page":"1999","DOI":"10.1007\/s10072-017-3091-6","volume":"38","author":"A Ghezzi","year":"2017","unstructured":"Ghezzi A, Bianchi A, Baroncini D, et al. A multicenter, observational, prospective study of self- and parent-reported quality of life in adolescent multiple sclerosis patients self-administering interferon-\u03b21a using RebiSmart\u2122-the FUTURE study. Neurol Sci. 2017;38(11):1999\u20132005. https:\/\/doi.org\/10.1007\/s10072-017-3091-6.","journal-title":"Neurol Sci"},{"key":"902_CR83","doi-asserted-by":"publisher","DOI":"10.1136\/bmjno-2021-000215","volume":"4","author":"L Krupp","year":"2022","unstructured":"Krupp L, Banwell B, Chitnis T, et al. Effect of fingolimod on health-related quality of life in paediatric patients with multiple sclerosis: results from the phase\u00a03 PARADIGMS Study. BMJ Neurol Open. 2022;4:e000215. https:\/\/doi.org\/10.1136\/bmjno-2021-000215.","journal-title":"BMJ Neurol Open"},{"issue":"4","key":"902_CR84","doi-asserted-by":"publisher","DOI":"10.3390\/jcm11175226","volume":"11","author":"L Rosa","year":"2022","unstructured":"Rosa L, Petracca M, Carotenuto A, et al. Quality of life changes in early-onset multiple sclerosis: a 4-year follow-up study. J Clin Med. 2022;11(4):5226. https:\/\/doi.org\/10.3390\/jcm11175226.","journal-title":"J Clin Med"},{"key":"902_CR85","doi-asserted-by":"crossref","unstructured":"O\u2019Mahony, Banwell B, Laporte A, et al. The health-related quality of life of children with multiple sclerosis is mediated by the health-related quality of life of their parents. Mult Scler. 2022;28(8):1299\u20131310.","DOI":"10.1177\/13524585211061521"},{"issue":"8","key":"902_CR86","doi-asserted-by":"publisher","DOI":"10.3390\/children11010071","volume":"11","author":"S Tarantino","year":"2024","unstructured":"Tarantino S, Proietti Checchi M, Papetti L, Monte G, Ferilli MAN, Valeriani M. Parental experiences in pediatric multiple sclerosis: insights from quantitative research. Children (Basel). 2024;11(8):71. https:\/\/doi.org\/10.3390\/children11010071.","journal-title":"Children (Basel)"},{"issue":"12","key":"902_CR87","doi-asserted-by":"publisher","first-page":"1502","DOI":"10.1177\/1352458509345902","volume":"15","author":"WS MacAllister","year":"2009","unstructured":"MacAllister WS, Christodoulou C, Troxell R, et al. Fatigue and quality of life in pediatric multiple sclerosis. Mult Scler. 2009;15(12):1502\u20138. https:\/\/doi.org\/10.1177\/1352458509345902.","journal-title":"Mult Scler"},{"issue":"Suppl 2","key":"902_CR88","doi-asserted-by":"publisher","first-page":"S4","DOI":"10.1212\/WNL.0000000000002879","volume":"87","author":"LB Krupp","year":"2016","unstructured":"Krupp LB, Rintell D, Charvet L, Milazzo M, Wassmer E. Pediatric multiple sclerosis. Perspectives from adolescents and their familes. Neurology. 2016;87(Suppl 2):S4\u20137. https:\/\/doi.org\/10.1212\/WNL.0000000000002879.","journal-title":"Neurology"},{"issue":"6","key":"902_CR89","doi-asserted-by":"publisher","DOI":"10.3390\/children8060445","volume":"8","author":"S Ghai","year":"2021","unstructured":"Ghai S, Kasilingam E, Lanzillo R, et al. Needs and experiences of children and adolescents with pediatric multiple sclerosis and their caregivers: a systematic review. Children. 2021;8(6):445. https:\/\/doi.org\/10.3390\/children8060445.","journal-title":"Children"},{"issue":"8","key":"902_CR90","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1177\/0883073819842420","volume":"34","author":"D Hebert","year":"2019","unstructured":"Hebert D, Geisthardt C, Hoffman H. Insights and recommendations from parents receiving a diagnosis of pediatric multiple sclerosis for their child. J Child Neurol. 2019;34(8):464\u201371. https:\/\/doi.org\/10.1177\/0883073819842420.","journal-title":"J Child Neurol"},{"issue":"12","key":"902_CR91","first-page":"2494","volume":"31","author":"JW Varni","year":"2004","unstructured":"Varni JW, Burwinkle TM, Szer IS. The PedsQL multidimensional fatigue scale in pediatric rheumatology: reliability and validity. J Rheumatol. 2004;31(12):2494\u2013500.","journal-title":"J Rheumatol"},{"issue":"10","key":"902_CR92","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1177\/08830738211015016","volume":"36","author":"C Gaudioso","year":"2021","unstructured":"Gaudioso C, Oo S, Mar S, Hendricks-Ferguson VL, Newland P, Varni JW. PedsQL multiple sclerosis module domain and item development: qualitative methods. J Child Neurol. 2021;36(10):901\u201310. https:\/\/doi.org\/10.1177\/08830738211015016.","journal-title":"J Child Neurol"}],"container-title":["Neurology and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40120-026-00902-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40120-026-00902-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40120-026-00902-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T14:07:32Z","timestamp":1778681252000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40120-026-00902-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,27]]},"references-count":92,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["902"],"URL":"https:\/\/doi.org\/10.1007\/s40120-026-00902-6","relation":{},"ISSN":["2193-8253","2193-6536"],"issn-type":[{"value":"2193-8253","type":"print"},{"value":"2193-6536","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,27]]},"assertion":[{"value":"12 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Paola Zaratin, Giampaolo Brichetto and Angelo Ghezzi declare no competing interests. Paola Zaratin and Angelo Ghezzi are Editorial Board members of the Neurology and Therapy journal. Paola and Angelo were not involved in the selection of peer reviewers for the manuscript nor any of the subsequent editorial decisions. Maria Pia Amato has received research grants by the National MS Society, Canadian MS Society, Italian Health Ministry, Regione Toscana, Bayer, Biogen, Merck, Novartis, Sanofi Genzyme, Teva, Almirall, Roche, and honoraria as a speaker and member of advisory boards by Bayer, Biogen, Merck, Novartis, Sanofi Genzyme, Teva, Almirall, Roche, Celgene BMS, and Sandoz. Anne Helme is employed by the Multiple Sclerosis International Federation (MSIF), which receives income from a wide range of sources, including healthcare and other companies: Biogen, Bristol Myers Squibb, Coloplast, F. Hoffman-La Roche, Merck, Novartis, Sandoz, Sanofi, and Viatris. Anne Helme declares no personal conflicts of interest. Brenda Banwell serves as a consultant to Novartis, Roche, and UCB.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"This article is based on previously conducted studies and does not contain any new studies with human participants or animals performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}}]}}